Images List Premium Download Classic

Uterine Fibroids

Uterine Fibroids-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Selective androgen receptor degrader (sard) ligands and methods of use thereof
University Of Tennessee Research Foundation
September 27, 2018 - N°20180273487

This invention is directed to pyrrole, pyrazole, imidazole, triazole, and morpholine based selective androgen receptor degrader (sard) compounds including heterocyclic anilide rings and their synthetic precursors, r-isomers, and non-hydroxylated and/or non-chiral propanamides, and pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, triple negative breast cancer, other cancers expressing the androgen receptor, ...
Methods of administering elagolix
Abbvie Inc.
August 23, 2018 - N°20180235963

The present disclosure relates to the use of gnrh receptor antagonists used in the treatment of endometriosis or uterine fibroids. In particular, the present disclosure describes a method of treating endometriosis or uterine fibroids, where the method involves the administration of elagolix, and where the method may further involve the co-administration of rifampin or ketoconazole..
Estrogen receptor beta partial agonist having estrogen receptor alpha inhibitory effect, and gynecological disease therapeutic ...
National University Corporation Tottori University
July 19, 2018 - N°20180200266

[problem] to provide a therapeutic agent for estrogen-dependent gynecological diseases such as endometriosis, uterine fibroids, and uterus adenomyosis. [solution] to use an estrogen receptor α-inhibiting β partial agonist represented by the formula (a), a pharmaceutically-acceptable salt thereof, or a hydrate of either of the afore-mentioned, as an active ingredient..
Uterine Fibroids Patent Pack
Download + patent application PDFs
Uterine Fibroids Patent Applications
Download + Uterine Fibroids-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Uterine Fibroids-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Selective androgen receptor degrader (sard) ligands and methods of use thereof
University Of Tennessee Research Foundation
May 03, 2018 - N°20180118663

This invention provides novel 3-amino propanamide selective androgen receptor degrader (sard) compounds, pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, androgenic alopecia or other hyperandrogenic dermal diseases, kennedy's disease, amyotrophic lateral sclerosis (als), and uterine fibroids, and to methods for reducing the levels of androgen receptor-full length (ar-fl) including pathogenic or resistance ...
Pigment epithelium derived factor (pedf) for the treatment of uterine fibroids
Ramot At Tel-aviv University Ltd.
February 15, 2018 - N°20180043001

A method of treating uterine fibroid in a subject in need thereof is provided. The method comprising administering to the subject a therapeutically effective amount of pigment epithelium-derived factor (pedf), thereby treating the uterine fibroid in the subject..
Embolic coils and related components, systems, and methods
Boston Scientific Scimed, Inc.
January 11, 2018 - N°20180008273

The present invention relates generally to systems and methods for delivering embolic devices into a body lumen of a patient. These embolic devices are applicable to a variety of neurological and/or peripheral applications.
Uterine Fibroids Patent Pack
Download + patent application PDFs
Uterine Fibroids Patent Applications
Download + Uterine Fibroids-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Uterine Fibroids-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Treatment method and product for uterine fibroids using purified collagenase
North Carolina Central University
November 23, 2017 - N°20170333356

The invention relates to compositions and methods for treating uterine fibroids, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid.. .
Method for treating uterine fibroids
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services
August 31, 2017 - N°20170246189

The invention relates to a method for treating uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17α-acetoxy-11β-[4-n,n-dimethylamino-phenyl) -19-norpregna-4,9-diene-3,20-dione (ulipristal) or any metabolite thereof. More particularly, the method is useful for reducing or stopping bleeding in a patient afflicted with uterine fibroids, and/...
Selective androgen receptor degrader (sard) ligands and methods of use thereof
University Of Tennessee Research Foundation
June 15, 2017 - N°20170166526

This invention provides novel indole, indazole, benzimidazole, indoline, quinolone, isoquinoline, and carbazole selective androgen receptor degrader (sard) compounds, pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, other ar-expressing cancers, androgenic alopecia or other hyper androgenic dermal diseases, kennedy's disease, amyotrophic lateral sclerosis (als), abdominal aortic aneurysm (aaa), and uterine fibroids, and to ...
Selective androgen receptor degrader (sard) ligands and methods of use thereof
University Of Tennessee Research Foundation
May 18, 2017 - N°20170137374

This invention provides novel 3-amino propanamide selective androgen receptor degrader (sard) compounds, pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, androgenic alopecia or other hyperandrogenic dermal diseases, kennedy's disease, amyotrophic lateral sclerosis (als), and uterine fibroids, and to methods for reducing the levels of androgen receptor-full length (ar-fl) including pathogenic or resistance ...
Selective androgen receptor degrader (sard) ligands and methods of use thereof
University Of Tennessee Research Foundation
April 06, 2017 - N°20170095446

This invention provides novel indole, indazole, benzimidazole, indoline, quinolone, isoquinoline, and carbazole selective androgen receptor degrader (sard) compounds, pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, androgenic alopecia or other hyper androgenic dermal diseases, kennedy's disease, amyotrophic lateral sclerosis (als), and uterine fibroids, and to methods for reducing the levels of androgen ...
Methods of administering elagolix
Abbvie Inc.
March 02, 2017 - N°20170056403

The present disclosure relates to the use of gnrh receptor antagonists used in the treatment of endometriosis or uterine fibroids. In particular, the present disclosure describes a method of treating endometriosis or uterine fibroids, where the method involves the administration of elagolix, and where the method may further involve the co-administration of rifampin or ketoconazole..
Selective androgen receptor degrader (sard) ligands and methods of use thereof
University Of Tennessee Research Foundation
February 23, 2017 - N°20170050921

This invention provides novel 3-amino propanamide selective androgen receptor degrader (sard) compounds, pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, androgenic alopecia or other hyperandrogenic dermal diseases, kennedy's disease, amyotrophic lateral sclerosis (als), and uterine fibroids, and to methods for reducing the levels of androgen receptor-full length (ar-fl) including pathogenic or resistance ...
Uterine Fibroids Patent Pack
Download + patent application PDFs
Uterine Fibroids Patent Applications
Download + Uterine Fibroids-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Uterine Fibroids-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
System and method for three-dimensional quantitative evaluaiton of uterine fibroids
Koninklijke Philips N.v.
November 17, 2016 - N°20160335770

A system (100) and method which assess the results of uterine fibroid embolization. A fibroid lesion is three-dimensionally segmented by a segmentation module (110) on contrast-enhanced arterial phase mri or cbct images and a differentiation process performed by a subtraction module (114) identifies actual contrast enhancement from background enhancement.
Surgical capture device and methods of use
Espiner Medical Ltd.
May 19, 2016 - N°20160135798

A surgical capture device is described that is configured to sequester tissue from a surgical cavity while the tissue is morcellated, or otherwise reduced in size. The capture device includes a side conduit that provides access to the interior of the device so that the tissue can be visualized during the morcellation process.
Progesteron receptor modulators for use in the therapy of uterine fibroids
Preglem Sa
February 11, 2016 - N°20160038510

The present invention relates to a long-term therapy including repeated treatment courses of ulipristal acetate or any metabolite thereof for treating uterine fibroids. The present invention also relates to a combined therapy applying ulipristal acetate with a progestin in order to improve the currently used treatment for uterine fibroids..
Method for treating uterine fibroids
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services
January 28, 2016 - N°20160022698

The invention relates to a method for treating uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17α-acetoxy-11β-[4-n,n-dimethylamino-phenyl)-19-norpregna-4,9-diene-3,20-dione (ulipristal) or any metabolite thereof. More particularly, the method is useful for reducing or stopping bleeding in a patient afflicted with uterine fibroids, and/...
Herbal composition and a method of treating uterine fibroids
Kang Li Biotech Co., Ltd.
January 07, 2016 - N°20160000846

The invention discloses an herbal composition of treating uterine fibroid. The herbal composition comprises antrodia cinnamomea, astragalus membranaceus, and leonurus japonicus; wherein the weight percentages of antrodia cinnamomea, astragalus membranaceus and leonurus japonicus are 25 to 75%, 20.8 to 62.5% and 4.2 to 12.5% by weight of the formula, respectively.
Loading